Operation and permanent low activity 125I brachytherapy for recurrent high-grade astrocytomas

被引:0
|
作者
机构
来源
Int J Radiat Oncol Biol Phys | / 3卷 / 541期
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Operation and permanent low activity I-125 brachytherapy for recurrent high-grade astrocytomas
    Halligan, JB
    Stelzer, KJ
    Rostomily, RC
    Spence, AM
    Griffin, TW
    Berger, MS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (03): : 541 - 547
  • [2] Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
    Congxiao Wang
    Shifeng Liu
    Lijing Peng
    Kaixian Zhang
    Wei Li
    Hao Zhang
    Ying Luan
    Peishun Li
    Xiaokun Hu
    BMC Cancer, 20
  • [3] Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas (vol 20, 591, 2020)
    Wang, Congxiao
    Liu, Shifeng
    Peng, Lijing
    Zhang, Kaixian
    Li, Wei
    Zhang, Hao
    Luan, Ying
    Li, Peishun
    Hu, Xiaokun
    BMC CANCER, 2020, 20 (01)
  • [4] Inverse automated treatment planning with and without individual optimization in interstitial permanent prostate brachytherapy with high- and low-activity 125I
    Pinkawa, M
    Maurer, U
    Mulhern, A
    Gagel, B
    Block, T
    Borchers, H
    Grieger, J
    Henkel, T
    Eble, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2003, 179 (06) : 417 - 422
  • [5] Prostate brachytherapy (LDR) with 125I permanent implantation;: Experience at CROB
    Cocco, G.
    Iadanza, L.
    Zucca, S.
    Castaldo, G.
    Lapadula, L.
    Montagna, A.
    Mazziotta, M.
    Imbriani, E.
    Silvestre, G.
    Fusco, V.
    ANNALS OF ONCOLOGY, 2006, 17 : VII153 - VII153
  • [6] Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
    Wu, Jing
    Yuan, Ying
    Priel, Debra A. Long
    Fink, Danielle
    Peer, Cody J.
    Sissung, Tristan M.
    Su, Yu-Ting
    Pang, Ying
    Yu, Guangyang
    Butler, Madison K.
    Mendoza, Tito R.
    Vera, Elizabeth
    Ahmad, Salman
    Bryla, Christine
    Lindsley, Matthew
    Grajkowska, Ewa
    Mentges, Kelly
    Boris, Lisa
    Antony, Ramya
    Garren, Nancy
    Siegel, Christine
    Lollo, Nicole
    Cordova, Christine
    Aboud, Orwa
    Theeler, Brett J.
    Burton, Eric M.
    Penas-Prado, Marta
    Leeper, Heather
    Gonzales, Javier
    Armstrong, Terri S.
    Calvo, Katherine R.
    Figg, William D.
    Kuhns, Douglas B.
    Gallin, John, I
    Gilbert, Mark R.
    CLINICAL CANCER RESEARCH, 2021, 27 (12) : 3298 - 3306
  • [7] MR of recurrent high-grade astrocytomas after intralesional immunotherapy
    Smith, MM
    Thompson, JE
    Castillo, M
    Cush, S
    Mukherji, SK
    Miller, CH
    Quattrocchi, KB
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1996, 17 (06) : 1065 - 1071
  • [8] CT-guided 125I brachytherapy for recurrent ovarian cancer
    Liu, Ping
    Tong, Lina
    Huo, Bin
    Dai, Dong
    Liu, Wenxin
    Wang, Ke
    Wang, Ying
    Guo, Zhi
    Ni, Hong
    ONCOTARGET, 2017, 8 (35) : 59766 - 59776
  • [9] Scintigraphic detection of 125I seeds after permanent brachytherapy for prostate cancer
    Kono, Yuzuru
    Kubota, Kazuo
    Mitsumoto, Takuya
    Tanaka, Akitomo
    Ishibashi, Akihiko
    Kobayashi, Kazumi
    Ito, Kimiteru
    Itami, Jun
    Kanemura, Mikio
    Minowada, Shigeru
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (04) : 541 - 545
  • [10] Permanent 125I prostate brachytherapy for castration-resistant prostate cancer
    Ding, Xue-Fei
    Huang, Tian-Bao
    Gao, Ying
    Lu, Sheng-Ming
    Tao, Hua-Zhi
    Xu, Jia-Nan
    Xu, Yao-Zong
    Wang, Fei
    Zhou, Yu-Quan
    Zhou, Guang-Chen
    Luan, Yang
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (02) : 278 - 283